QD-Sol

Company Overview

Snapshot

Founded in May 2018 by Maya Leventer-Roberts, QD-Sol operated with 1–10 employees. The company ceased operations in March 2022.

Business overview

QD-Sol developed an AI-based application designed to generate personalized and prioritized treatment plans for patients, aligning with clinical guidelines and individual preferences. This technology enables patients to track risk stratification for various conditions and compare the effects of multiple interventions. The platform integrates with electronic health records to automatically upload clinical and lab measurements, utilizing causal inference to determine the individualized treatment effect of changing risk factors. QD-Sol operated in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Medical Decision Support, targeting both patients and healthcare providers with its B2B2C business model.

Company Intelligence Q&A

What is QD-Sol's primary offering?

QD-Sol developed an AI-based application that provides tangible, personalized, and prioritized treatment plans for patients, based on current clinical guidelines and individual preferences.

When was QD-Sol founded and by whom?

QD-Sol was founded in May 2018 by Maya Leventer-Roberts.

What technology does QD-Sol utilize in its risk calculator?

QD-Sol's risk calculator incorporates state-of-the-art causal inference to discover the individualized treatment effect of changing each risk factor on an individual's overall risk.

How does QD-Sol's application integrate with existing healthcare systems?

The application is designed to automatically upload dozens of clinical and lab measurements from any established electronic health record, eliminating the need for patients to manually input or remember them.

What is the current operational status of QD-Sol?

QD-Sol ceased to operate in March 2022.